Follow
Juan Fortea
Juan Fortea
Neurólogo, Hospital de Sant Pau
Verified email at santpau.cat
Title
Cited by
Cited by
Year
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
11342015
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
6392017
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
5512014
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
4862015
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
3072016
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need
GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ...
Alzheimer's & Dementia 15 (2), 292-312, 2019
1842019
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ...
Neurology 85 (7), 626-633, 2015
1382015
Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers
J Fortea, R Sala-Llonch, D Bartrés-Faz, B Bosch, A Llado, N Bargallo, ...
Journal of Alzheimer's Disease 22 (3), 909-922, 2010
1352010
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
1322018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ...
The Lancet Neurology 17 (10), 860-869, 2018
1252018
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
O Dols-Icardo, A García-Redondo, R Rojas-García, R Sánchez-Valle, ...
Human molecular genetics 23 (3), 749-754, 2014
1232014
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
A Leuzy, K Chiotis, SG Hasselbalch, JO Rinne, A de Mendonça, M Otto, ...
Brain 139 (9), 2540-2553, 2016
1152016
Reduced slow-wave sleep is associated with high cerebrospinal fluid Aβ42 levels in cognitively normal elderly
AW Varga, ME Wohlleber, S Giménez, S Romero, JF Alonso, EL Ducca, ...
Sleep 39 (11), 2041-2048, 2016
1132016
Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease
J Fortea, E Vilaplana, D Alcolea, M Carmona‐Iragui, ...
Annals of neurology 76 (2), 223-230, 2014
1122014
Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer’s disease: potential and limitations
M Cosín-Tomás, A Antonell, A Lladó, D Alcolea, J Fortea, M Ezquerra, ...
Molecular neurobiology 54 (7), 5550-5562, 2017
1112017
Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease
D Alcolea, M Carmona-Iragui, M Suárez-Calvet, MB Sánchez-Saudinós, ...
Journal of Alzheimer's Disease 42 (1), 157-167, 2014
1102014
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
D Bergeron, ML Gorno‐Tempini, GD Rabinovici, MA Santos‐Santos, ...
Annals of neurology 84 (5), 729-740, 2018
1032018
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ...
The Lancet 395 (10242), 1988-1997, 2020
1002020
Cerebrospinal fluid clearance in Alzheimer disease measured with dynamic PET
MJ De Leon, Y Li, N Okamura, WH Tsui, LA Saint-Louis, L Glodzik, ...
Journal of Nuclear Medicine 58 (9), 1471-1476, 2017
972017
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
ED Hamlett, EJ Goetzl, A Ledreux, V Vasilevko, HA Boger, A LaRosa, ...
Alzheimer's & Dementia 13 (5), 541-549, 2017
962017
The system can't perform the operation now. Try again later.
Articles 1–20